An infection with linezolid-resistant S. aureus in a patient with left ventricular assist system

Axel Kola1, Philip Kirschner, Bernhard Gohrbandt

  • 1Institute of Medical Microbiology and Hospital Epidemiology, Hannover, Germany. kola.axel@mh-hannover.de

Insights

A patient with a left ventricular assist device developed a linezolid-resistant Staphylococcus aureus infection. Caution is advised when using linezolid with invasive devices or for extended durations.

Area of Science:

  • Infectious Diseases
  • Antimicrobial Resistance
  • Cardiology

Background:

  • Invasive cardiovascular devices, such as left ventricular assist systems (LVAS), are associated with a risk of device-related infections.
  • Staphylococcus aureus is a common pathogen causing device-related infections.
  • Linezolid is a critical antibiotic for treating serious Gram-positive infections, including those caused by MRSA.

Observation:

  • A case of infection with linezolid-resistant Staphylococcus aureus (LRSA) is reported in a patient with an LVAS.
  • The patient's infection highlights a significant challenge in treating device-associated infections.

Findings:

  • The emergence of linezolid resistance in Staphylococcus aureus poses a therapeutic challenge, particularly in patients with indwelling medical devices.
  • Previous documented cases of LRSA are summarized, indicating a growing concern.

Implications:

  • Linezolid should be used with caution in patients with invasive devices or foreign materials.
  • Extended therapeutic courses of linezolid (>14 days) may increase the risk of resistance development.
  • Vigilance and alternative treatment strategies are necessary for LRSA infections in high-risk patients.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...